Want to see GB:SPEC full AI Analyst Report?
Inspecs Group Plc (SPEC) AI Stock Analysis
Inspecs Group Plc
(LSE:SPEC)
The overall score is heavily pressured by the company's weak financial performance, marked by persistent losses, deteriorating cash flow, and rising leverage. Technicals show a stock in a short-term pullback with weak momentum, while the negative P/E ratio underscores a lack of earnings power. The primary risk is the company's inability to achieve sustainable profitability and generate consistent cash flow.
Inspecs Group Plc (SPEC) vs. iShares MSCI United Kingdom ETF (EWC)
- Market Cap
- GBP 97.17M
- Dividend Yield
- ―
- Average Volume (3M)
- 5,652
- Price to Earnings (P/E)
- -37.9
- Beta (1Y)
- 0.52
- Revenue Growth
- 0.20%
- EPS Growth
- 33.75%
- Country
- UK
- Employees
- 1,656
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Medical - Instruments & Supplies
Inspecs Group Plc Business Overview & Revenue Model
Company Description
INSPECS Group plc designs, produces, sells, markets, and distributes fashion eyewear, lenses, and OEM products in the United Kingdom, Europe, North America, South America, Asia, Africa, and Australia. It operates through Frames and Optics; Manufactur...
How the Company Makes Money
Inspecs Group makes money primarily by selling eyewear products—most notably optical frames and related eyewear components—to business customers such as optical retailers, distributors, and other eyewear companies. Its revenue model is largely wholes...
Inspecs Group Plc Financial Statement Overview
Summary
Financial health is weak. Revenue is declining, gross margins have contracted significantly, and net losses persist. Operating cash flow has nearly vanished, leading to negative free cash flow, while rising leverage and negative return on equity raise liquidity and solvency concerns.
Income Statement
30NegativeBalance Sheet
35NegativeCash Flow
25Negative| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 193.23M | 191.70M | 198.26M | 203.29M | 200.96M | 182.62M |
| Gross Profit | 90.63M | 87.37M | 103.45M | 103.55M | 98.86M | 85.78M |
| EBITDA | 19.10M | 17.49M | 15.75M | 17.27M | 11.20M | 6.05M |
| Net Income | -997.00K | -6.51M | -4.61M | -997.00K | -6.32M | ― |
Balance Sheet | ||||||
| Total Assets | 203.41M | 202.23M | 220.25M | 221.91M | 292.68M | 326.36M |
| Cash, Cash Equivalents and Short-Term Investments | 25.96M | 15.99M | 23.96M | 20.07M | 26.80M | 29.76M |
| Total Debt | 54.88M | 59.78M | 62.47M | 62.12M | 69.78M | 69.44M |
| Total Liabilities | 115.92M | 122.51M | 121.56M | 118.39M | 162.59M | 181.13M |
| Stockholders Equity | 87.49M | 79.72M | 98.69M | 103.52M | 130.09M | 145.22M |
Cash Flow | ||||||
| Free Cash Flow | -308.00K | -2.26M | 4.28M | 6.92M | 842.00K | 12.37M |
| Operating Cash Flow | 1.21M | 93.00K | 7.20M | 12.66M | 5.08M | 19.75M |
| Investing Cash Flow | -1.30M | -2.65M | -2.52M | -6.18M | -4.19M | -15.66M |
| Financing Cash Flow | 1.28M | -4.85M | -426.00K | -8.84M | -4.40M | 1.26M |
Inspecs Group Plc Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:SPEC, the sentiment is Negative. The current price of 88.50 is below the 20-day moving average (MA) of 90.08, below the 50-day MA of 93.09, and above the 200-day MA of 87.59, indicating a neutral trend. The MACD of -1.00 indicates Negative momentum. The RSI at 0.80 is Positive, neither overbought nor oversold. The STOCH value of 41.67 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for GB:SPEC.
Inspecs Group Plc Peers Comparison
Overall Rating
GB:CVSG55Neutral- GB:SPEC43Neutral
Financial Indicators
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| GB:SPEC | Inspecs Group Plc | 88.50 | 26.00 | 41.60% | |
| GB:CVSG | CVS Group plc | 1327.00 | 63.79 | 5.05% |
Inspecs Group Plc Corporate Events
Inspecs Board Change Follows Completion of Bidco Takeover
NeutralInspecs Group plc, a global eyewear solutions provider with a vertically integrated business model, produces branded and OEM optical frames, sunglasses, safety eyewear and low vision aids for retailers and opticians worldwide. The Group’s exten...
Inspecs appoints new CFO to steer next phase of global eyewear growth
PositiveInspecs Group plc has appointed Robert Brodie as its new Chief Financial Officer, with plans for him to join in autumn 2026 and take a seat on the board as an executive director, succeeding Chris Kay, who will remain as a consultant to ensure a smoot...
Inspecs shareholders back ordinary AGM resolutions but reject specials
NeutralInspecs Group plc, a leading global eyewear designer and manufacturer, produces branded and private-label optical frames, sunglasses, safety eyewear and low vision products, supported by vertically integrated operations across Europe, Asia and the U....
Inspecs secures Qualcomm investment and smart eyewear partnership
PositiveInspecs Group has secured a $10m (£7.5m) strategic equity investment from Qualcomm Technologies via a subscription for 7.5m new shares at £1 each, with the funds earmarked to support growth and general working capital. The move modestly dil...
Inspecs Publishes Annual Report and Sets Date for 2026 AGM
NeutralInspecs Group plc has posted its latest Annual Report and Accounts and the notice of its upcoming Annual General Meeting, making these documents available to shareholders on its website. The AGM is scheduled to take place on 30 June 2026 at 11:00 a.m...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Aug 21, 2026